|
Market Cap (20-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 12 April 2021, 9:18. The announcement is not marked as price sensitive, and is 2 page(s) in length and 219.81kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDC was 0.004% short sold according to ASIC data. It was ranked the 603rd most shorted stock on the ASX. It is now ranked as the 544th most shorted stock on the ASX with 0.017% of total shares short sold as of the latest reported data (31 August 2021).
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| NanaBis Observational Study progress update | 12 April 2021, 9:18 |
| Notification of Investor Webinar - NanaBis Phase III Trial | 8 April 2021, 8:53 |
| Intention to Grant EU Notice NanoCelle | 7 April 2021, 8:23 |
| Executive and Management changes | 31 March 2021, 11:32 |
You must be logged in to post a reply.
Medlab Clinical 